National Institutes of Health: Glucose Intolerance trials

The registry lists 12 Glucose Intolerance studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 1 1Phase 2 5Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Type 1 Diabetes Extension StudyRecruitingNCT02734277
• CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1CompletedNCT01773707Phase 2Results posted
• Mifepristone Effects on Glucose Intolerance in Obese/Overweight AdultsCompletedNCT01419535Phase 1/2Results posted
• Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"CompletedNCT01030861Phase 2Results posted
• Mood and Insulin Resistance in Adolescents At-Risk for DiabetesCompletedNCT01425905Phase 2
• Age, Lifestyle, Muscle Mechanisms in Insulin ResistanceCompletedNCT00971594Not applicable
• Rosiglitazone to Treat Patients With Heart Failure and Glucose Intolerance or Type II DiabetesCompletedNCT00064727Phase 2
• Type 2 Diabetes Primary Prevention for At Risk GirlsCompletedNCT00063674Not applicable
• Lifestyle Interventions to Reduce Diabetes RiskCompletedNCT00006162Not applicable
• Health Effects of Liposuction in Overweight Women With Elevated Insulin Levels, Impaired Glucose Tolerance and/or Type 2 DiabetesCompletedNCT00005760
• Diabetes Prevention ProgramCompletedNCT00004992Phase 3
• Prevalence of Carbohydrate Intolerance in Lean and Obese ChildrenStatus unknownNCT00000112